Work with experts to take discoveries from lab to market.
Bring Innovations to Life in the Real World
The Discovery to Market program is another pillar of Carey's innovative curriculum. Learn how to assess the commercial potential of scientific discoveries and technological innovations with real-world discoveries from across Johns Hopkins University.
Working alongside experts in entrepreneurship, law, regulation, technology, science, and strategy, you’ll gain the valuable experience and competencies employers are looking for when hiring Chief Innovation Officers and informed CEOs who can truly understand the complex interplay of science, technology and innovation to create revolutionary business models for companies around the world.
WHAT MAKES D2M UNIQUE?
- We focus on commercialization and entrepreneurship as a means to meet societal needs. By creating a successful business model a technology can be brought to market for medical, scientific and humanitarian purposes.
- The program is guided by a core philosophy that emphasizes hands-on, real-world experience.
- Students learn critical aspects of science and the fundamentals of the technology commercialization process that moves innovations from the lab to the marketplace.
- Participants in the program have diverse cultural, professional and business backgrounds. They work together to pool their knowledge to understand the technical aspects of each engagement. There are no science, medical or engineering prerequisites.
- Working in teams, students determine the feasibility of commercializing real scientific inventions such as biomarkers, medical devices, pharmaceuticals and biologics, and health IT
- Industry experts in entrepreneurship, law and regulation, technology, strategy, science, and medicine advise student teams throughout the project.
- Our working agreements with project partners mean that you’ll be working on real inventions, not theoretical cases.
The Johns Hopkins Carey Business School works closely with the Johns Hopkins University School of Medicine (JHUSOM), School of Biomedical Engineering (BME) and the Center for Bioengineering Innovation and Design (CBID), the office of Johns Hopkins Technology Transfer (JHTT), the U.S. Army Medical Research and Material Command Telemedicine & Advanced Technology Research Center (TATRC), and National Institute of Health (NIH).